Health & Biotech
Health & Biotech
Here’s what we’re getting wrong about the war against cancer
Health & Biotech
Creso Pharma’s South Africa sales begin with Cannamics
Health & Biotech
Clock’s Ticking: In 24 hours we’ll know if Opthea’s DME clinical trial was successful
Stockhead TV
StockTalk: Biotechs set to boom with clinical trial floodgates open
Health & Biotech
Dr Boreham’s Crucible: Volpara is all about breasts but in no danger of going bust
Health & Biotech
New investors back HeraMed’s latest raise to the tune of $2.3m
Health & Biotech
Bug killer Bio-Gene is safe in water: study
Health & Biotech
Dimerix drug chosen for global COVID-19 study, shares surge 122pc
Health & Biotech
StockDoc: Data collected through social media could be a game changer for the healthcare sector
Health & Biotech
Small but mighty: The ASX health small caps aiming to beat the government in the innovation game
Health & Biotech
Creso is perfectly poised for growth in the huge Brazilian market
Health & Biotech
COVID-19 hasn’t hurt cannabis clinical trials … much
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.